Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) NEULACTIL pericyazine 2.5mg tablet 84 tablets
Section 19A approved medicine
(Approval lapsed) NEULACTIL pericyazine 2.5mg tablet 84 tablets
Section 19A approval holder
Sanofi-Aventis Australia Pty Ltd ABN 31 008 558 807
Phone
1800 818 806
Approved until
Status
Expired
Medicines in short supply/unavailable
NEULACTIL periciazine 2.5mg tablet blister pack - ARTG 27524
Indication(s)
Severe anxiety and tension states and the maintenance treatment of the psychotic patient. It is useful in controlling such symptoms as impulsiveness and aggression.
Additional information